NSC |
Compound |
Enrichment |
Correlation |
NSC 173905 |
Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- |
0.00770426557728506 |
0.51156807 |
NSC 628676 |
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4-aminophenyl)amino]-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,5-dimethoxyphenyl)-, dihydrochloride |
0.00770426557728506 |
0.24093605 |
NSC 628917 |
3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide |
0.00770426557728506 |
0.54641745 |
NSC 636859 |
Cuspidatin C |
0.00770426557728506 |
0.41442519 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.00792181575650983 |
0.20712645 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00792181575650983 |
0.38096677 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.00792181575650983 |
0.28324888 |
NSC 23925 |
Null |
0.00792181575650983 |
0.23655243 |
NSC 244404 |
Null |
0.00792181575650983 |
0.34055532 |
NSC 303861 |
L-Cysteine analog |
0.00792181575650983 |
0.58477807 |